At Breathonix, we offer you a new proactive way to perform a Breath test in a non-Invasive way and detect diseases while being Accurate and Affordable. Our mission is to put an end to the billion-dollar diagnostic industry and make it accessible to everyone in need. Breathonix BreFence™ Go COVID-19 Breath Test System has gained Singapore HSA Provisional Approval.
Accelerated: Total turnaround time from breath sampling to results takes less than 60 seconds.
Accurate: BreFence™ Go has an accuracy of 85.7% sensitivity and 97% specificity with non-AI. Clinical Trials are ongoing with AI to further improve accuracy.
Affordable: Each breath test is significantly more affordable than a PCR swab test and does not require a trained healthcare professional to operate.
- Sample Breath: Instruct user to exhale into a disposable one-way valve mouthpiece
- Real-time Analysis: Measure and analyse VOCs biomarkers in the breath sample by the BreFence™ Go Breath Test System
- Instant Results: Obtain the results in 60 seconds with just 3 clicks. Start, Stop and Send.
Ongoing clinical trials to detect a wide range of diseases including early detection of Lung Cancer, Nasopharyngeal Cancer and Tuberculosis.
- Slingshot 2019 MedTech Winner
Breathonix was the MedTech Sector Winner (out of 2400 startups) of Slingshot 2019 competition. - 6+ Years of Breath Analysis Research
The technology is developed from 6+ years of breath analysis research in National University of Singapore (NUS). - Backed by Reputable Investors
Funded by NUS Enterprise, Origin and Antler.
